Novo Nordisk (NVO) stock eyes China oral Wegovy filing within months. CEO confirms timeline as Lilly leads and generic competition looms in 2026. The post Novo Nordisk (NVO) Stock: Oral Wegovy Pill Filing in China Imminent appeared first on…
Source link
Be the first to comment